Letter to the Editor: Toll-Like Receptor Antagonists as a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Letter to the Editor: Toll-Like Receptor Antagonists as a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients

Published:2021-06-01 Issue:5 Volume:34 Page:361-362
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Safaei Sadegh¹²³,Karimi-Googheri Masoud¹²⁴

Affiliation:

1. Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.

2. Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.

3. Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.

4. Department of Clinical Laboratory, Shafa Hospital, Kerman University of Medical Sciences, Kerman, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2020.0074

Reference18 articles.

1. TLR4: An Important Molecule Participating in Either Anti-Human Papillomavirus Immune Responses or Development of Its Related Cancers

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Therapeutic Target Critical for SARS-CoV-2 Infectivity and Induction of the Cytokine Release Syndrome;Cells;2023-05-07

2. Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond;Cells;2022-07-14

3. COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by TLR7 gene polymorphism (rs3853839) in middle-aged individuals without previous comorbidities;Gene Reports;2022-06

4. Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19;Frontiers in Immunology;2021-11-11

5. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2;Immunogenetics;2021-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3